Company: RNGE
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0001641172-25-001343
Chunk: 249

Company: RANGE IMPACT, INC.
Filing Date: 2025-03-31
Form: 10-K
Item: Item 1C
Chunk 249
---
 Because such statements include risks and uncertainties, many of which are beyond
our control, actual results may differ materially from those expressed or implied by such forward-looking statements. Some of the factors
that could cause actual results to differ materially from those expressed or implied by such forward-looking statements can be found
under the caption “Risk Factors” in Part I, Item 1A, and elsewhere in this Annual Report. The forward-looking statements
speak only as of the date on which they are made, and we undertake no obligation to update such statements to reflect events that occur
or circumstances that exist after the date on which they are made.

The
following discussion should be read in conjunction with the financial statements and the accompanying notes for the periods ended December
31, 2024 and December 31, 2023 appearing elsewhere in this Annual Report. Our actual results could differ materially from those expressed
or implied in any forward-looking statements as a result of various factors, including those set forth under the caption “Risk
Factors” in Part I, Item 1A.

Items
Affecting Comparability of Financial Results

During
the year ended December 31, 2023, the Company purchased Collins Building, as described in Note 2 to the Consolidated Financial
Statements. During the year ended December 31, 2024, the Company sold substantially all of the assets of Collins Building to its
previous owner in exchange for the cancellation of all remaining debt owed to him, as described in more detail in Note 2.

During
the third quarter of 2024, the Company sold its wholly-owned subsidiary Graphium Biosciences, Inc. In accordance with GAAP, assets and
liabilities of discontinued operations are presented separately in the Consolidated Balance Sheets, and results of discontinued operations
are reported as a separate component of consolidated net loss in the Consolidated Statements of Operations, for all periods presented,
resulting in changes to the presentation of certain prior period amounts.

Plan
of Operations

We
are a public company dedicated to improving the health and wellness of people and the planet through a novel and innovative approach
to impact investing. We own and operate several complementary operating businesses focused on developing long-term solutions to environmental,
social, and health challenges, with a particular focus on acquiring, reclaiming and repurposing mine sites and other undervalued land
in economically disadvantaged communities throughout Appalachia. We take an opportunistic approach to impact investing by leveraging
our competitive advantages and looking at solving old problems in